Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical Trial.
Wenzhe FanBowen ZhuShuling ChenYanqin WuXiao ZhaoLiangliang QiaoZhen HuangRong TangJinghua ChenWan Yee LauMinshan ChenJiaping LiMing KuangZhenwei PengPublished in: JAMA oncology (2024)
ClinicalTrials.gov Identifier: NCT04103398.
Keyphrases